These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25688502)

  • 1. Evaluation of chemoradiotherapy with carbon ions and the influence of p53 mutational status in the colorectal carcinoma cell line HCT 116.
    Adeberg S; Baris D; Habermehl D; Rieken S; Brons S; Weber KJ; Roth W; Debus J; Combs SE
    Tumori; 2014; 100(6):675-84. PubMed ID: 25688502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro.
    Schlaich F; Brons S; Haberer T; Debus J; Combs SE; Weber KJ
    Radiat Oncol; 2013 Nov; 8():260. PubMed ID: 24192264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines.
    El Shafie RA; Habermehl D; Rieken S; Mairani A; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i113-9. PubMed ID: 23824114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells.
    Combs SE; Zipp L; Rieken S; Habermehl D; Brons S; Winter M; Haberer T; Debus J; Weber KJ
    Radiat Oncol; 2012 Jan; 7():9. PubMed ID: 22284807
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Schneider T; Zwicker F; Huber PE; Debus J; Hauswald H
    In Vivo; 2023; 37(5):1951-1959. PubMed ID: 37652498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
    Greco FA; Rodriguez GI; Shaffer DW; Hermann R; Litchy S; Yardley DA; Burris HA; Morrissey LH; Erland JB; Hainsworth JD
    Oncologist; 2004; 9(6):644-52. PubMed ID: 15561808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX).
    Rinaldi Y; Pointet AL; Khemissa Akouz F; Le Malicot K; Wahiba B; Louafi S; Gratet A; Miglianico L; Laharie H; Bouhier Leporrier K; Thirot Bidault A; Texereau P; Coriat R; Terrebonne E; Gouttebel MC; Malka D; Bachet JB; Lepage C; Taieb J;
    Eur J Cancer; 2020 Sep; 136():25-34. PubMed ID: 32623182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines.
    Combs SE; Bohl J; Elsasser T; Weber KJ; Schulz-Ertner D; Debus J; Weyrather WK
    Int J Radiat Biol; 2009 Feb; 85(2):126-37. PubMed ID: 19280465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.
    Hainsworth JD; Spigel DR; Raefsky EL; Kuzur ME; Yost K; Kommor M; Litchy S; Greco FA
    Cancer; 2005 Nov; 104(9):1992-7. PubMed ID: 16130138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53.
    Chendil D; Oakes R; Alcock RA; Patel N; Mayhew C; Mohiuddin M; Gallicchio VS; Ahmed MM
    Cancer; 2000 Nov; 89(9):1893-900. PubMed ID: 11064345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
    Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
    Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of preferred chemotherapeutics for combining with a CHK1 inhibitor.
    Xiao Y; Ramiscal J; Kowanetz K; Del Nagro C; Malek S; Evangelista M; Blackwood E; Jackson PK; O'Brien T
    Mol Cancer Ther; 2013 Nov; 12(11):2285-95. PubMed ID: 24038068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines - does scheduling matter?
    Harrabi S; Combs SE; Brons S; Haberer T; Debus J; Weber KJ
    Int J Radiat Biol; 2013 Sep; 89(9):692-7. PubMed ID: 23577964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan in the first-line treatment of patients with carcinoma of unknown primary site: a randomized, phase III Sarah Cannon Oncology Research Consortium Trial.
    Hainsworth JD; Spigel DR; Clark BL; Shipley D; Thompson DS; Farley C; West-Osterfield K; Lane CM; Cescon T; Bury MJ; Greco FA
    Cancer J; 2010; 16(1):70-5. PubMed ID: 20164695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.
    Combs SE; Habermehl D; Kieser M; Dreher C; Werner J; Haselmann R; Jäkel O; Jäger D; Büchler MW; Debus J
    BMC Cancer; 2013 Sep; 13():419. PubMed ID: 24034562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Choong NW; Vokes EE; Haraf DJ; Tothy PK; Ferguson MK; Kasza K; Rudin CM; Hoffman PC; Krauss SA; Szeto L; Mauer AM
    J Thorac Oncol; 2008 Jan; 3(1):59-67. PubMed ID: 18166842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of combined temozolomide and radiotherapy using X  rays and high-linear energy transfer radiation for glioblastoma.
    Barazzuol L; Jena R; Burnet NG; Jeynes JC; Merchant MJ; Kirkby KJ; Kirkby NF
    Radiat Res; 2012 May; 177(5):651-62. PubMed ID: 22468703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-platinum gemcitabine combinations in non-small cell lung cancer.
    Marx G; Harper P
    Lung Cancer; 2002 Nov; 38 Suppl 2():S51-4. PubMed ID: 12431830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon beam therapy in recurrent ovarian cancer.
    Nawa A; Suzuki K; Kato S; Fujiwara S; Kajiyama H; Shibata K; Ino K; Nakamura S; Kikkawa F
    Ann Oncol; 2008 Jan; 19(1):192-4. PubMed ID: 18084046
    [No Abstract]   [Full Text] [Related]  

  • 20. [Developed new agents for lung cancer].
    Kato Y; Saijo N
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.